Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7Sanofi

02 1Shire Human Genetic Therapies AB

03 2Takeda Pharmaceutical

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : USA

AGALSIDASE BETA

Brand Name : FABRAZYME

Dosage Form : VIAL; INTRAVENOUS

Dosage Strength : 5MG/VIAL

Packaging :

Approval Date :

Application Number : 103979

Regulatory Info :

Registration Country : USA

Sanofi Company Banner

02

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : USA

AGALSIDASE BETA

Brand Name : FABRAZYME

Dosage Form : VIAL; INTRAVENOUS

Dosage Strength : 35MG/VIAL

Packaging :

Approval Date :

Application Number : 103979

Regulatory Info :

Registration Country : USA

Sanofi Company Banner

03

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Sweden

agalsidase beta

Brand Name : Fabrazyme

Dosage Form : POWDER FOR CONCENTRATE FOR

Dosage Strength : -

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Sanofi Company Banner

04

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Prescription

Registration Country : Canada

AGALSIDASE BETA

Brand Name : FABRAZYME

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 5MG/VIAL

Packaging : 1.1ML

Approval Date :

Application Number : 2248965

Regulatory Info : Prescription

Registration Country : Canada

Sanofi Company Banner

05

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Prescription

Registration Country : Canada

AGALSIDASE BETA

Brand Name : FABRAZYME

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 35MG/VIAL

Packaging : 7.2ML

Approval Date :

Application Number : 2248966

Regulatory Info : Prescription

Registration Country : Canada

Sanofi Company Banner

06

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Originator

Registration Country : South Africa

Agalsidase beta

Brand Name : Fabrazyme 35mg

Dosage Form : POI

Dosage Strength : 35mg/20ml

Packaging : 20X1mg/20ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

07

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : Originator

Registration Country : South Africa

Agalsidase beta

Brand Name : Fabrazyme 5mg

Dosage Form : POI

Dosage Strength : 5mg/5ml

Packaging : 5X1mg/5ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Sanofi Company Banner

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

AGALSIDASE ALFA

Brand Name : REPLAGAL

Dosage Form : SOLUTION

Dosage Strength : 1MG/ML

Packaging :

Approval Date :

Application Number : 2249057

Regulatory Info : Prescription

Registration Country : Canada

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Agalsidase Alfa

Brand Name : Replagal

Dosage Form : INF

Dosage Strength : 1mg/ml

Packaging : 3.5X1mg/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

10

Shire Human Genetic Therapies AB

Country
2024 ACI Convention
Not Confirmed
arrow

Shire Human Genetic Therapies AB

Country
arrow
2024 ACI Convention
Not Confirmed

agalsidas alfa

Brand Name : Replagal

Dosage Form : KONCENTRAT TILL INFUSIONSVÄTSKA, LÖSNING

Dosage Strength : 1 MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank